PORTAL: Program on Regulation, Therapeutics, and Law
  • About Us
    • What is PORTAL?
    • Core Faculty
    • Research Team
    • Affiliated Faculty & Researchers
    • Expert Roundtable
  • Our Work
    • Publications
    • Policy Action
    • Literature Scan
    • In the Press
    • Media Center
    • Teaching
    • CeBIL
    • Biomarkers >
      • About The Project
      • The PBRC Team
      • Our Collaborators
      • AERO Graph
      • Workshops
      • Biomarkers2018
  • Blog
  • Events
    • #policyethx 2020-2021
    • Events Archive >
      • #policyethx 2019-2020
      • #policyethx 2018-2019
      • #policyethx 2017-2018
      • #policyethx 2016-2017
      • Biosimilar Insulin
      • Older Events
  • Join Us
    • PORTAL Fellowship
  • Contact
    • Inquiries
    • E-mail List
  • About Us
    • What is PORTAL?
    • Core Faculty
    • Research Team
    • Affiliated Faculty & Researchers
    • Expert Roundtable
  • Our Work
    • Publications
    • Policy Action
    • Literature Scan
    • In the Press
    • Media Center
    • Teaching
    • CeBIL
    • Biomarkers >
      • About The Project
      • The PBRC Team
      • Our Collaborators
      • AERO Graph
      • Workshops
      • Biomarkers2018
  • Blog
  • Events
    • #policyethx 2020-2021
    • Events Archive >
      • #policyethx 2019-2020
      • #policyethx 2018-2019
      • #policyethx 2017-2018
      • #policyethx 2016-2017
      • Biosimilar Insulin
      • Older Events
  • Join Us
    • PORTAL Fellowship
  • Contact
    • Inquiries
    • E-mail List

Jing Luo, M.D., M.P.H.

Picture
Dr. Luo is an Instructor in Medicine at Harvard Medical School and a faculty member in the Division of Pharmacoepidemiology and Pharmacoeconomics. He graduated from Duke University and the University of Illinois at Chicago College of Medicine, where he was an NIH-Fogarty International Clinical Research Scholar. He trained in Primary Care Internal Medicine at Yale-New Haven Hospital and obtained a Masters of Public Health at the Harvard T.H. Chan School of Public Health as part of a general medicine fellowship. Dr. Luo is Board Certified in Internal Medicine and serves as an associate physician at the Phyllis Jen Center for Primary Care at BWH and at Harvard University Health Services. His research focuses on prescription drug pricing, access to medicines and generic competition. Dr. Luo’s work has appeared in JAMA, JAMA Internal Medicine, Lancet Diabetes & Endocrinology and the Harvard Health Policy Review. He also serves as a clinical consultant to Alosa Health, a non-profit organization that promotes evidence-based prescribing and academic detailing.

Back to Core Faculty
Picture
Program On Regulation, Therapeutics And Law (PORTAL)
Division of Pharmacoepidemiology and Pharmacoeconomics
1620 Tremont Street, Suite 3030
Boston, MA 02120
CONTACT